---
title: "Novavax, Inc. (NVAX.US) Q1 2022 Earnings Conference Call"
description: "Novavax is a clinical biotechnology company specialized in discovery, development, and commercialization of vaccines for infectious diseases prevention. The com"
locale: "en"
url: "https://longbridge.com/en/lives/12164"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Novavax, Inc. (NVAX.US) Q1 2022 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Novavax is a clinical biotechnology company specialized in discovery, development, and commercialization of vaccines for infectious diseases prevention. The company makes use of its proprietary recombinant nanoparticle vaccine technology to produce candidate vaccines to counter known and emerging disease threats. Its vaccine candidates include ResVax and NanoFlu. The company also develops immunostimulatory saponin-based adjuvants via its wholly-owned Swedish subsidiary NovavaxAB. The company was founded in 1987 and is headquartered in Gaithersburg, Maryland.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.